The triple negative subtype appeared to be a part of the BRCA genetic testing criteria; however, the proportion of patients with triple negative breast cancer in those with an L63X and BRCA1 positive status in our study was much higher than that in those who were BRCA 1/2 negative. Here, BRCA1 is linked to triple-negative breast carcinoma.